How to Build Reference Packs for Medical Writing?
A reference pack, often called a ref-pack or refpack, is the combination of the newly created document, or target document, together with a pack of full of reference papers used. The ref-pack supports the claims in the target document for pharmaceutical companies during medical, legal, and regulatory review (MLR review).
For a medical writer or review team, it is a controlled evidence set that lets someone answer a specific question quickly, see where each claim comes from, and judge whether the source is fit for purpose. That distinction is the foundation of how to build reference packs that support real medical, scientific, and regulatory work. It is for this reason that ref-packs are part of pharmaceutical industry's MLR review.
A weak pack creates work later. Reviewers hunt for missing context, writers cite a secondary source when the primary study is available, and teams spend hours checking whether a paper is current, relevant, or duplicated. A well-built pack reduces that friction before drafting begins.
Start with the decision the pack must support
The first question is not, “What can we find on this topic?” It is, “What must this pack enable the user to do?” The answer changes the literature you include, the detail you capture, and the way you organize it.
A pack for a manuscript background section may need landmark studies, recent systematic reviews, and mechanistic evidence. A pack for a clinical expert meeting may need treatment guidelines, pivotal trials, safety publications, and evidence that explains areas of uncertainty. A pack supporting a medical information response may require the exact source language behind a narrow, approved question.
Write a one- or two-sentence scope statement before searching. Define the population, intervention or exposure, condition, outcome, timeframe, and intended deliverable. This is not bureaucracy. It prevents a familiar failure mode: collecting interesting papers that never answer the actual brief.
Be equally clear about exclusions. If the assignment concerns adults with moderate-to-severe disease, decide whether pediatric data, preclinical studies, conference abstracts, or studies outside a defined treatment setting belong in the pack. Some may be useful as context, but they should not be mixed indistinguishably with core evidence.
How to build reference packs with a search strategy
A search strategy should be proportionate to the job. A rapid pack for an internal outline and a comprehensive pack for a publication plan do not require the same depth. What they do require is traceability: another qualified person should be able to understand what was sought, what was selected, and why.
Begin by translating the scope into search concepts. Include disease terminology, common abbreviations, intervention names, relevant outcomes, and study designs where appropriate. Medical terminology shifts over time, so include older terms and spelling variants when the evidence base is mature. For drug-related topics, distinguish molecule, class, formulation, route, and dose if those distinctions affect the question.
Search trusted bibliographic sources and authoritative documents appropriate to the purpose. Then document the essentials: the date searched, databases or source types used, key concepts, date limits, language limits, and any screening criteria. You do not always need a full systematic-review protocol, but you do need enough information to make the pack defensible.
Citation chasing is often where the highest-value sources appear. Review the reference lists of key guidelines, systematic reviews, pivotal studies, and major consensus statements. Check what later publications have cited an influential trial, particularly when safety, long-term outcomes, subgroup findings, or methodology have evolved.
Select evidence by role, not just relevance
Relevance alone is not enough. Every source should have a job in the pack. A useful way to screen material is to assign a simple evidence role: foundational background, guideline or consensus, primary efficacy study, safety study, real-world evidence, methodology, or contextual commentary.
This role-based approach prevents an overstuffed pack dominated by reviews. Reviews can orient the team, identify landmark research, and summarize a field, but they may not be the right citation for a precise efficacy or safety statement. Whenever a claim depends on a specific endpoint, population, analysis, or limitation, locate and retain the primary source.
Assess quality in context. Study design, sample size, comparators, outcome definitions, follow-up duration, statistical approach, funding, and conflicts of interest can all affect how a source should be used. A small observational study is not automatically unhelpful, but it should not silently carry the same evidentiary weight as a well-conducted randomized trial or current clinical guideline.
Recency also depends on the question. For disease epidemiology or treatment recommendations, current evidence is often essential. For a historical mechanism or a landmark trial, an older publication may remain central. Replace outdated guidance, but do not discard seminal evidence simply because of its publication date.
Capture the details that make the pack usable
A citation alone is not a reference pack. The person using it still has to open the paper, locate the relevant section, and decide whether it supports the intended point. Add structured notes while screening, when the paper is fresh and the context is visible.
For each included reference, capture the full citation, persistent identifier, publication type, evidence role, and a concise relevance note. Record the population, study design, intervention or comparator, primary outcomes, and key results that matter for the assignment. Include limitations and caveats in plain language. If the reference supports a potential claim, write that claim carefully and avoid turning an exploratory finding into a definitive conclusion.
Page, table, figure, or supplementary-material locations are especially helpful for lengthy publications. They save time during drafting and help reviewers verify an assertion without rereading a 20-page article. For guidelines, capture the recommendation wording, strength or level of evidence where provided, and the relevant patient subgroup.
A useful pack also identifies what a reference does not establish. For example, a trial may demonstrate short-term efficacy in a selected population but offer limited evidence on comparative effectiveness, long-term safety, or applicability to routine practice. This makes the pack more honest and more valuable to writers.
Organize for the person who comes next
The best structure depends on the deliverable. For a narrative review, grouping by theme or clinical question may work best. For a slide deck, organization by key message can speed drafting. For a dossier or evidence response, source hierarchy and claim mapping may be more practical.
Whatever structure you choose, separate core references from supplementary reading. Core references are the sources likely to be cited or scrutinized. Supplementary sources provide background, methodological support, or useful context without being essential to the central evidence narrative.
Use consistent naming and version control. A pack should show its title, owner, date created, date last updated, scope, and status. If it has been refreshed after a new guideline, safety signal, or pivotal publication, make that visible. Unlabeled “final” folders are rarely final and often create uncertainty about which evidence set was actually used.
When confidential briefs, unpublished materials, or client strategy are involved, the environment matters as much as the organization. Medical teams should know where documents are processed, who can access them, and whether content is retained or used for model training. CORTIX.io is designed around confidentiality-conscious, domain-specific medical workflows, which is a meaningful distinction when evidence handling cannot be treated as a casual research task.
Keep a human in the middle of the workflow
AI can reduce the repetitive work, and indeed AI reference packs reduce time spend on finding citations, extracting metadata, clustering topics, and producing first-pass relevance notes. It should not become the final authority on scientific meaning. The HiTM, or human in the middle, principle puts qualified medical professionals in control of source selection, interpretation, claim framing, and final quality checks.
That human check is where context is protected. A tool may identify a relevant publication, but a medical writer or subject-matter reviewer determines whether the endpoints match the brief, whether the population is applicable, and whether a conclusion is appropriately qualified. HiTM also catches practical issues such as incorrect citation metadata, duplicate reports from the same study, and unsupported wording before they reach a deliverable.
Review, refresh, and hand off with confidence
Before sharing the pack, perform a final quality review. Confirm that all core sources are accessible, citations are complete, duplicates are resolved, and summaries reflect the original publications. Check that reviews have not replaced essential primary evidence and that current guidelines or major recent data have been considered.
Then look for gaps. A gap is not always a problem to hide. It may be the most useful finding in the pack: no long-term data, limited representation of a patient subgroup, inconsistent endpoint definitions, or no direct comparison between treatments. Flagging these limitations helps teams write accurately and gives reviewers a clear view of the evidence landscape.
A strong reference pack gives medical peeps something more useful than a large reading list. It gives them a transparent route from question to evidence to carefully supported communication - and a practical starting point when the next brief lands on their desk.
